Toxins in Neurodegenerative Diseases: The Cause and the Cure
A special issue of Toxins (ISSN 2072-6651).
Deadline for manuscript submissions: closed (20 September 2023) | Viewed by 5553
Special Issue Editor
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases are frequent in the elderly, and due to the increase in life expectancy, the number of cases has grown significantly in recent years. Alzheimer’s disease, the main type of dementia, affected 46.8 million people in 2015, being the 7th cause of death in the world. Few specific pharmacological treatments are available so far, and other options only increase life expectancy. Aiming at an effective treatment, studies are needed for a better understanding of the disease mechanisms to further develop pharmacological therapies. In this context, venoms and secretions, which contain a wide ‘chemical library’, can provide toxins useful as tools for these studies and new treatments.
This Special Issue is focused on the use of venoms and toxins (obtained from animals, plants, microorganisms, etc.) to understand the mechanism of neurodegenerative diseases, to identify new molecular/pharmacological targets, and to share new compounds to treat these uncurable diseases. Original experimental or in silico research, short communications, and review articles are welcome.
Prof. Dr. Juliana Mozer Sciani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- venom
- toxin
- neurodegenerative diseases
- dementia
- new molecules
- mechanism of the disease
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
